5
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T65816 |
Prolyl-4-hydroxylase Inhibitor 11
|
Others | Others |
Prolyl-4-hydroxylase Inhibitor 11 是一种新型脯氨酸4-羟化酶抑制剂,对普通小球藻(Chlorella vulgaris)氧化应激和 Cu(II)毒性的保护作用。 | |||
T4277 |
Osilodrostat
LCI699 |
Glucocorticoid Receptor; Others; Hydroxylase | Endocrinology/Hormones; Metabolism; Others |
Osilodrostat (LCI699) 是一种有效的人11β-羟化酶和醛固酮合成酶抑制剂,IC50分别值为2.5 和0.7nM。 | |||
T28272 |
Osilodrostat phosphate
LCI699 phosphate,LCI 699 phosphate,LCI-699 phosphate |
||
Osilodrostat phosphate is a potent oral 11β-hydroxylase inhibitor. | |||
T33370 |
Metyrapol
SU 5236,SU-5236,SU5236 |
||
Metyrapol is a competitive inhibitor of 11-deoxycorticosterone hydroxylation by 11β-hydroxylase. | |||
T30741 |
Carboetomidate
|
||
Carboetomidate is an analog of etomidate and does not bind to 11β -hydroxylase with high affinity. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T14001 |
11-Beta-hydroxyandrostenedione
4-雄烯-11β-醇-3,17-二酮,NSC-17102,4-Androsten-11β-ol-3,17-dione |
Endogenous Metabolite | Metabolism |
11-Beta-hydroxyandrostenedione (NSC-17102) 是主要存在于肾上腺的类固醇,也是 11β-羟基类固醇脱氢酶同工酶抑制剂。随着 4-androstenedione 的提高,通过测量血浆中的11-Beta-hydroxyandrostenedione,能够区分高雄激素血症的肾上腺或卵巢起源。 | |||
T36915 |
21-Deoxycortisol
|
||
21-Deoxycortisol is a corticosteroid metabolite of 17-hydroxyprogesterone produced in the adrenal glandvia11-hydroxylation by 11β-hydroxylase.1,2Serum levels of 21-deoxycortisol are elevated in patients with congenital adrenal hyperplasia that are heterozygous for mutations inCYP2A21, the gene encoding steroid 21-hydroxylase, and have been used as a biomarker for the detection of 21-hydroxylase deficiencies. 1.Fiet, J., Villette, J.-M., Galons, H., et al.The application of a new highly-sensitive... | |||
T36472 |
Tetrahydro-11-deoxy Cortisol
|
||
Tetrahydro-11-deoxy cortisol (THS) is the primary urinary metabolite of 11-deoxycortisol. Urinary excretion of THS is elevated in patients with 11β-hydroxylase deficiency, a condition resulting from mutations in the cytochrome P450 (CYP) isoform CYP11B1. Urinary levels of THS are also elevated in patients with adrenocortical carcinoma (ACC) and adrenocortical adenoma (ACA) but are higher in patients with ACC compared to ACA. |